BPA
BMRN icon

Beacon Pointe Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Beacon Pointe Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,316
Closed -$237K – 1391
2025
Q2 		$237K Sell
4,316
-2,847
-40% -$168K ﹤0.01% 1140
2025
Q1 		$506K Buy
7,163
+1,399
+24% +$94.1K 0.01% 844
2024
Q4 		$379K Sell
5,764
-4,906
-46% -$329K ﹤0.01% 924
2024
Q3 		$750K Buy
10,670
+526
+5% +$44K 0.01% 713
2024
Q2 		$835K Sell
10,144
-4,466
-31% -$372K 0.01% 697
2024
Q1 		$1.28M Sell
14,610
-3,228
-18% -$289K 0.01% 615
2023
Q4 		$1.72M Sell
17,838
-133
-0.7% -$11.8K 0.02% 517
2023
Q3 		$1.59M Sell
17,971
-356
-2% -$31.7K 0.02% 515
2023
Q2 		$1.59M Sell
18,327
-729
-4% -$68.6K 0.03% 419
2023
Q1 		$1.85M Buy
19,056
+1,372
+8% +$142K 0.03% 414
2022
Q4 		$1.83M Buy
17,684
+2,645
+18% +$248K 0.04% 374
2022
Q3 		$1.27M Sell
15,039
-253
-2% -$22.5K 0.03% 414
2022
Q2 		$1.27M Sell
15,292
-1,125
-7% -$89.6K 0.03% 416
2022
Q1 		$1.27M Buy
16,417
+1,499
+10% +$125K 0.02% 553
2021
Q4 		$1.32M Sell
14,918
-1,764
-11% -$146K 0.03% 328
2021
Q3 		$1.29M Buy
16,682
+9,260
+125% +$731K 0.03% 369
2021
Q2 		$619K Buy
+7,422
New +$588K 0.02% 433

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Beacon Pointe Advisors's BMRN Position: Q3 2025 in Review

Beacon Pointe Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2025, closing a stake of 4,316 shares — an estimated $237K sold.

Beacon Pointe Advisors first reported a position in BMRN in Q2 2021 and held it in 17 quarters. The position peaked at $1.85M in Q1 2023. 576 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Beacon Pointe Advisors reported no remaining BioMarin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Beacon Pointe Advisors sold 4,316 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $237K.
  • Beacon Pointe Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Beacon Pointe Advisors's BioMarin Pharmaceuticals position peaked at $1.85M in Q1 2023.
  • 576 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Beacon Pointe Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.